Prospective Randomized Study: Assessment of PRF Efficacy in Prevention of Jaw Osteonecrosis After Tooth Extraction
PRF
Prospective Randomized Clinical Study: Role of Platelet Rich Fibrin (PRF) in the Tooth Extraction Site in the Prevention of Jaw Osteonecrosis on Patients Under Bisphosphonates Therapy
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
This date has not been verified as actual or estimated.
Primary Completion
January 2016
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
January 2017
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Brief Summary
This prospective study will include patients taking or having taken bisphosphonates and needing dental extractions.
The aim of this study is to validate the contribution of PRF (Platelet Rich Fibrin) in tooth extraction sites.
In the test group (PRF) and in the control group (no PRF), we use the same atraumatic extraction protocol associated with the same antibiotic procedure.
Registry Overview
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Recruitment status
unknown
Estimated enrollment
100 participants
Study completion date
January 2017
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Listed locations
1 countries · 3 sites
Trial Relationships
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Related Scientific Literature
Loading related publications...
Study Timeline
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
Study Start
January 2014
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
July 15, 2014
Actual (reported)
First Posted
July 23, 2014
Actual (reported)
Primary Completion
January 2016
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
January 2017
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Number of jaw osteonecrosis after tooth extraction
7 symptoms \> 6 weeks for the diagnosis of osteonecrosis:
* bone exposure
* bone spicule
* mucosal inflammation
* pain
* paresthésias
* suppuration
* jaw fracture
* number of jaw osteonecrosis after tooth extraction in the oral bisphosphonates group in comparison with the IV bisphosphonates group
1year
Other Outcomes (2)
Contribution of comorbidities factors in the appearance of osteonecrosis
1 year
Number of days in tooth-extraction healing in the two groups
2 months
Study Arms (2)
tooth extraction and insertion of PRF
ACTIVE COMPARATOR
Experimental: Atraumatic tooth extraction with antibiotics( amoxicillin clavulanate combination) .Insertion of PRF membrane in tooth-extraction site.
Drug: tooth extraction with antibiotics (amoxicillin- clavulanate, clindamycine)Procedure: atraumatic extraction
No PRF
PLACEBO COMPARATOR
Atraumatic extraction with antibiotic without PRF insertion
Drug: tooth extraction with antibiotics (amoxicillin- clavulanate, clindamycine)Procedure: atraumatic extraction
Interventions
tooth extraction with antibiotics (amoxicillin- clavulanate, clindamycine)Drug
BPs per os\< 3ans: amoxicillin- clavulanate J-1 à J+10
BPs IV ou per os\> 3ans ou per os + comordibities (diabetes, immunosuppression, tobacco):
amoxicillin- clavulanate J-3 à J+10
In case of allergy:
BPs per os: clindamycine J-1 à J+10
BPs IV ou per os\> 3ans ou per os + comordibities (diabetes, immunosuppression, tobacco):
clindamycine J-3 à J+10
Also known as: antibiotherapy before and after extraction
No PRFtooth extraction and insertion of PRF
atraumatic extractionProcedure
Eligibility Criteria
Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
You may qualify if:
patients taking bisphosphonates whatever the indication, the type, the administration and the duration of treatment (we include patients taking or having taken bisphosphonates, even several years ago)
And who need tooth extraction (not recoverable in conservative dentistry and symptomatic tooth: dental and periodontal infections, symptomatic traumatic tooth fracture).
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
January 2017
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
July 23, 2014
Record last verified: 2014-07
Source record
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.